文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

ICU内急性脑损伤有创通气成人的预防性抗生素:系统评价与Meta分析

Prophylactic Antibiotics in Adults With Acute Brain Injury Who Are Invasively Ventilated in the ICU: A Systematic Review and Meta-Analysis.
PubMed 文献 · Chest · 2024-10-28
一句话结论系统评价与Meta分析显示,预防性抗生素未显著降低急性脑损伤有创通气成人住院死亡率(RR 0.91,95%CI 0.70-1.17,P=.39),但可能与呼吸机相关性肺炎减少相关(RR 0.56,95%CI 0.35-0.89)。

该系统评价与Meta分析检索随机对照试验,纳入7项RCT共835例ICU内急性脑损伤接受有创机械通气的成人。与安慰剂或常规治疗相比,预防性肠外抗生素的住院死亡率合并RR为0.91(95%CI 0.70-1.17;P=.39;低确定性),呼吸机相关性肺炎合并RR为0.56(95%CI 0.35-0.89;低确定性)。机械通气时长(MD -2.0天;95%CI -6.1至2.1天;极低确定性)与ICU入住时长(MD -2.2天;95%CI -5.4至1.1天;极低确定性)组间相似。作者认为现有RCT证据未就预防性抗生素对死亡率的影响提供确定性证据。

要点

  • 预防性肠外抗生素未显著降低住院死亡率:合并RR 0.91(95%CI 0.70-1.17;P=.39;低确定性)。
  • 预防性抗生素与呼吸机相关性肺炎减少相关:合并RR 0.56(95%CI 0.35-0.89;低确定性)。
  • 机械通气时长组间相似:MD -2.0天(95%CI -6.1至2.1天;极低确定性)。
  • ICU入住时长组间相似:MD -2.2天(95%CI -5.4至1.1天;极低确定性)。
  • 7项RCT共835例,无试验被判定为高偏倚风险;作者认为现有证据未就死亡率影响提供确定性证据。

适用人群与场景

  • ICU内接受有创机械通气的急性脑损伤成人。

研究设计与关键结果

  • 系统评价与Meta分析,检索随机对照试验及未发表试验,最终纳入7项RCT共835例。
  • 主要终点住院死亡率:预防性抗生素合并RR 0.91(95%CI 0.70-1.17;P=.39;低确定性)。
  • 次要终点呼吸机相关性肺炎:合并RR 0.56(95%CI 0.35-0.89;低确定性)。
  • 次要终点机械通气时长:MD -2.0天(95%CI -6.1至2.1天;极低确定性)。
  • 次要终点ICU入住时长:MD -2.2天(95%CI -5.4至1.1天;极低确定性)。
  • 无试验被判定为高偏倚风险。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入7项随机对照试验。
  • 证据确定性:住院死亡率为低确定性;呼吸机相关性肺炎为低确定性;机械通气时长为极低确定性;ICU入住时长为极低确定性(采用GRADE方法评价)。
  • 作者结论:现有随机临床试验证据未就预防性抗生素对死亡率的影响提供确定性证据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为现有随机临床试验证据未就预防性抗生素对ICU内接受有创机械通气的急性脑损伤成人死亡率的影响提供确定性证据。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Lower respiratory tract infections are common in patients receiving invasive mechanical ventilation in an ICU after an acute brain injury and may have deleterious consequences.

RESEARCH QUESTION: In adults with acute brain injury receiving invasive mechanical ventilation in an ICU, is the administration of prophylactic parenteral antibiotics, compared with placebo or usual care, associated with reduced mortality?

STUDY DESIGN AND METHODS: We conducted a systematic review and meta-analysis. We searched for randomized clinical trials in electronic databases, as well as unpublished trials. The primary outcome was hospital mortality, and secondary outcomes included the incidence of ventilator-associated pneumonia, ICU length of stay, and duration of mechanical ventilation. We used a random effects model to estimate the pooled risk ratio (RR) with corresponding 95% CI for binary outcomes and the mean difference (MD) with 95% CI for continuous outcomes. Certainty of evidence was evaluated using Grading of Recommendations Assessment Development and Evaluation methods.

RESULTS: One thousand seven hundred twenty-eight reports of studies were screened, with 7 randomized controlled trials recruiting 835 participants included. No trials were adjudicated as having a high risk of bias. The pooled estimated RR for mortality associated with the use of prophylactic antibiotics was 0.91 (95% CI, 0.70-1.17; P = .39; low certainty). The pooled estimated RR for ventilator-associated pneumonia was 0.56 (95% CI, 0.35-0.89; low certainty). The pooled estimated duration of mechanical ventilation for those allocated to prophylactic antibiotics compared with control participants (MD, -2.0 days; 95% CI, -6.1 to 2.1 days; very low certainty) and duration of ICU admission (MD, -2.2 days; 95% CI, -5.4 to 1.1 days; very low certainty) were similar.

INTERPRETATION: Current evidence from randomized clinical trials does not provide definitive evidence regarding the effect of prophylactic antibiotics on mortality in patients receiving invasive mechanical ventilation in the ICU.

CLINICAL TRIAL REGISTRY: International Prospective Register of Systematic Reviews; No.: CRD42023424732; URL: https://www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Hadley-Brown K, Hailstone L, Devane R, et al. Prophylactic Antibiotics in Adults With Acute Brain Injury Who Are Invasively Ventilated in the ICU: A Systematic Review and Meta-Analysis. Chest. 2024. PMID: 39490972. doi:10.1016/j.chest.2024.10.031

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。